BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19168793)

  • 1. Increased T-bet+ cytotoxic effectors and type I interferon-mediated processes in chronic graft-versus-host disease of the oral mucosa.
    Imanguli MM; Swaim WD; League SC; Gress RE; Pavletic SZ; Hakim FT
    Blood; 2009 Apr; 113(15):3620-30. PubMed ID: 19168793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice.
    Ikeda A; Aoki N; Kido M; Iwamoto S; Nishiura H; Maruoka R; Chiba T; Watanabe N
    Hepatology; 2014 Jul; 60(1):224-36. PubMed ID: 24700550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR3 <-> ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host disease.
    Wenzel J; Lucas S; Zahn S; Mikus S; Metze D; Ständer S; von Stebut E; Hillen U; Bieber T; Tüting T
    J Am Acad Dermatol; 2008 Mar; 58(3):437-42. PubMed ID: 18280341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.
    Hakim FT; Memon S; Jin P; Imanguli MM; Wang H; Rehman N; Yan XY; Rose J; Mays JW; Dhamala S; Kapoor V; Telford W; Dickinson J; Davis S; Halverson D; Naik HB; Baird K; Fowler D; Stroncek D; Cowen EW; Pavletic SZ; Gress RE
    J Immunol; 2016 Nov; 197(9):3490-3503. PubMed ID: 27694491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of FoxP3(+) regulatory T cells in the target tissues and blood in chronic graft versus host disease.
    Imanguli MM; Cowen EW; Rose J; Dhamala S; Swaim W; Lafond S; Yagi B; Gress RE; Pavletic SZ; Hakim FT
    Leukemia; 2014 Oct; 28(10):2016-27. PubMed ID: 24577531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell chimerism in oral mucosa of transplanted patients affected by graft-versus-host disease.
    Pérez CA; Rabanales R; Rojas-Alcayaga G; Larrondo M; Escobar AF; López MN; Salazar-Onfray F; Alfaro JI; González FE
    J Oral Pathol Med; 2016 Feb; 45(2):127-35. PubMed ID: 26102283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal cell-mediated immunological changes associated with experimental graft-versus-host disease.
    Thomas DW; Matthews JB; Prime SS
    J Oral Pathol Med; 1996 Apr; 25(4):145-50. PubMed ID: 8809681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse Activity of IL-17
    Klimczak A; Suchnicki K; Sedzimirska M; Lange A
    Arch Immunol Ther Exp (Warsz); 2019 Oct; 67(5):311-323. PubMed ID: 31177288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
    Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensive dental caries in patients with oral chronic graft-versus-host disease.
    Castellarin P; Stevenson K; Biasotto M; Yuan A; Woo SB; Treister NS
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1573-9. PubMed ID: 22516054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD.
    Croudace JE; Inman CF; Abbotts BE; Nagra S; Nunnick J; Mahendra P; Craddock C; Malladi R; Moss PA
    Blood; 2012 Nov; 120(20):4246-55. PubMed ID: 23012327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production.
    Whiting D; Hsieh G; Yun JJ; Banerji A; Yao W; Fishbein MC; Belperio J; Strieter RM; Bonavida B; Ardehali A
    J Immunol; 2004 Jun; 172(12):7417-24. PubMed ID: 15187119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and histopathological features of the oral mucosa in allogeneic haematopoietic stem cell transplantation patients.
    Demarosi F; Lodi G; Carrassi A; Moneghini L; Sarina B; Sardella A
    Exp Oncol; 2007 Dec; 29(4):304-8. PubMed ID: 18199988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-bet Promotes Acute Graft-versus-Host Disease by Regulating Recipient Hematopoietic Cells in Mice.
    Fu J; Wu Y; Nguyen H; Heinrichs J; Schutt S; Liu Y; Liu C; Jin J; Anasetti C; Yu XZ
    J Immunol; 2016 Apr; 196(7):3168-79. PubMed ID: 26903480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral chronic graft-vs.-host disease characterization using the NIH scale.
    Fassil H; Bassim CW; Mays J; Edwards D; Baird K; Steinberg SM; Williams KM; Cowen EW; Mitchell SA; Hakim FT; Taylor T; Avila D; Zhang D; Grkovic L; Datiles M; Gress RE; Pavletic SZ
    J Dent Res; 2012 Jul; 91(7 Suppl):45S-51S. PubMed ID: 22699667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-bet is critical for the development of acute graft-versus-host disease through controlling T cell differentiation and function.
    Fu J; Wang D; Yu Y; Heinrichs J; Wu Y; Schutt S; Kaosaard K; Liu C; Haarberg K; Bastian D; McDonald DG; Anasetti C; Yu XZ
    J Immunol; 2015 Jan; 194(1):388-97. PubMed ID: 25404360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of cytokines, chemokines and chemokine receptors in the initiation and progression of chronic GVHD.
    Hayashida JN; Nakamura S; Toyoshima T; Moriyama M; Sasaki M; Kawamura E; Ohyama Y; Kumamaru W; Shirasuna K
    Bone Marrow Transplant; 2013 Jan; 48(1):115-23. PubMed ID: 22659679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome.
    Hildebrandt GC; Corrion LA; Olkiewicz KM; Lu B; Lowler K; Duffner UA; Moore BB; Kuziel WA; Liu C; Cooke KR
    J Immunol; 2004 Aug; 173(3):2050-9. PubMed ID: 15265940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research.
    Mays JW; Fassil H; Edwards DA; Pavletic SZ; Bassim CW
    Oral Dis; 2013 May; 19(4):327-46. PubMed ID: 23107104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Langerhans cells and T cells in oral graft versus host disease and oral lichen planus.
    Hasséus B; Jontell M; Brune M; Johansson P; Dahlgren UI
    Scand J Immunol; 2001 Nov; 54(5):516-24. PubMed ID: 11696204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.